• Home
  • About us
    • Prolonging Remission
    • Management
    • Board
    • Collaborators
  • Development
    • Development Program
    • Supporting Papers
  • For Patients
  • For Clinicians
  • Donate
  • News
  • Contact
News
Recent Updates

EpiAxis expands its Phase 1 metastatic breast cancer trial

Posted by Admin 3 months ago

EpiAxis Therapeutics, a University of Canberra spin out company, has expanded its clinical trial pro

EpiAxis recruits FPI for its Phase 1B clinical trial

Posted by Admin 1 year ago

EpiAxis Phase 1 FPI News Release

Media Release

Posted by Admin 2 years ago

Get In Touch